Last10K.com

Sigma Aldrich Corp (SIAL) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Sigma Aldrich Corp

CIK: 90185 Ticker: SIAL

Exhibit 99.1

 

LOGO

3050 Spruce Street, St. Louis, MO 63103 USA

Tel: (800) 521-8956 (314) 771-5765    Fax: (800) 325-5052 (314) 771-5757

 

From:   Rakesh Sachdev     For questions, contact:
  President and CEO     Sondra S. Brown
      Director, Investor Relations
      (314) 236-8763

FOR IMMEDIATE RELEASE - St. Louis, MO, February 9, 2012

SIGMA-ALDRICH (NASDAQ: SIAL) REPORTS DILUTED EPS OF $0.89, A 17% INCREASE

AND 5% SALES GROWTH FOR Q4 2011. FULL YEAR 2011 DILUTED EPS INCREASED

14%. 2012 DILUTED EPS EXPECTED TO INCREASE TO $3.90 TO $4.05

HIGHLIGHTS:

2011 Results (all percentages are to comparable periods in 2010)

Q4 Results

 

 

Reported sales increased 5% to $610 million. Sales grew organically by 3% with Research and Fine Chemicals (“SAFC”) sales growing organically by 1% and 7%, respectively. Acquisitions contributed 2% to sales growth.

 

 

Net income was $108 million, up 15% from Q4 2010.

 

 

Reported diluted EPS was $0.89, up 17% from Q4 2010. Excluding a one-time tax item in 2011 adjusted EPS was $0.91 in Q4 2011.

Full Year 2011 Results

 

 

Sales grew 10% to $2.5 billion. Sales grew organically by 5% with Research and SAFC contributing 3% and 9% respectively to organic growth.

 

 

Net income was $457 million, up 19% from 2010.

 

 

Reported diluted EPS was $3.72, up 19% from 2010. Excluding restructuring, diluted adjusted EPS was $3.76, up 14% over the prior year.

 

 

2011 net cash provided by operating activities and free cash flow were $495 million and $391 million, respectively.

2012 Outlook (all percentages are compared to full year 2011 results)

 

 

Organic sales growth for the full year is expected to be in the mid single digit range assuming market conditions similar to late 2011, with lower sales growth in the first half of 2012 and higher sales growth later in the year. The recently completed acquisition of BioReliance Holdings, Inc. (“BioReliance”) is expected to increase 2012 sales growth by about 5%. At current exchange rates, currency rate changes are expected to reduce otherwise reportable sales growth for the full year by approximately 2%.

 

1


The following information was filed by Sigma Aldrich Corp (SIAL) on Thursday, February 9, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Sigma Aldrich Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sigma Aldrich Corp.

Continue

Assess how Sigma Aldrich Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sigma Aldrich Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Income
Consolidated Statements Of Stockholders' Equity
Consolidated Statements Of Stockholders' Equity (parenthetical)
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (components Of Accumulated Other Comprehensive Income, Net Of Tax) (details)
Accumulated Other Comprehensive Income (narrative) (details)
Accumulated Other Comprehensive Income (tables)
Allowance For Doubtful Accounts
Allowance For Doubtful Accounts (changes In Allowance For Doubtful Accounts) (details)
Allowance For Doubtful Accounts (tables)
Common Stock
Common Stock (narrative) (details)
Common Stock (summary Of The Combined Stock Option Activity And Other Data For The Company's Stock Option Plans) (details)
Common Stock (summary Of The Company's Nonvested Performance Units) (details)
Common Stock (tables)
Common Stock (weighted-average Assumptions Under The Black-scholes Option-pricing Model For Stock Option Grants) (details)
Company Operations By Business Unit
Company Operations By Business Unit (geographic Financial Information - Long-lived Assets) (details)
Company Operations By Business Unit (geographic Financial Information - Net Sales To Unaffiliated Customers) (details)
Company Operations By Business Unit (net Sales For The Company's Business Units) (details)
Company Operations By Business Unit (tables)
Company Operations By Business Unit (united States Sales To Unaffiliated Customers) (details)
Contingent Liabilities And Commitments
Earnings Per Share
Earnings Per Share (shares Used In Calculation Of Earnings Per Share) (details)
Earnings Per Share (tables)
Financial Derivatives And Risk Management
Financial Derivatives And Risk Management (narrative) (details)
Income Taxes
Income Taxes (changes In Total Gross Unrecognized Tax Benefits) (details)
Income Taxes (components Of Income Before Income Taxes) (details)
Income Taxes (deferred Tax Assets And Liabilities, Netted By Taxing) (details)
Income Taxes (items Accounting For The Difference Between Income Taxes At Federal Statutory Rate And Effective Tax Rate) (details)
Income Taxes (narrative) (details)
Income Taxes (net Deferred Tax Assets And Liabilities) (details)
Income Taxes (provision For Income Taxes) (details)
Income Taxes (tables)
Intangible Assets
Intangible Assets (amortizable And Unamortizable Intangible Assets) (details)
Intangible Assets (change In Net Goodwill) (details)
Intangible Assets (narrative) (details)
Intangible Assets (tables)
Inventories
Inventories (narrative) (details)
Inventories (principal Categories Of Inventories) (details)
Inventories (tables)
Lease Commitments
Lease Commitments (minimum Rental Commitments For Non-cancelable Leases) (details)
Lease Commitments (narrative) (details)
Lease Commitments (tables)
Long-term Debt
Long-term Debt (narrative) (details)
Long-term Debt (schedule Of Long-term Debt Additional Information) (details)
Long-term Debt (schedule Of Long-term Debt) (details)
Long-term Debt (tables)
Notes Payable
Notes Payable (schedule Of Notes Payable Additional Information) (details)
Notes Payable (schedule Of Notes Payable) (details)
Notes Payable (tables)
Other Assets And Liabilities
Other Assets And Liabilities (other Assets) (details)
Other Assets And Liabilities (other Current Assets) (details)
Other Assets And Liabilities (other Current Liabilities) (details)
Other Assets And Liabilities (other Liabilities) (details)
Other Assets And Liabilities (tables)
Pension And Other Post-retirement Benefit Plans
Pension And Other Post-retirement Benefit Plans (amounts Recognized In Consolidated Balance Sheets) (details)
Pension And Other Post-retirement Benefit Plans (components Of The Net Periodic Benefit Costs) (details)
Pension And Other Post-retirement Benefit Plans (expected Employer Contributions And Benefit Payments) (details)
Pension And Other Post-retirement Benefit Plans (fair Value Measurements) (details)
Pension And Other Post-retirement Benefit Plans (narrative) (details)
Pension And Other Post-retirement Benefit Plans (post Retirement Benefits Recognized In Other Comprehensive Income) (details)
Pension And Other Post-retirement Benefit Plans (rate Assumptions Associated With The Pension And Post-retirement Medical Benefit Plans To Determine Benefit Obligations And Additional Year-end Information) (details)
Pension And Other Post-retirement Benefit Plans (rate Assumptions Associated With The Pension And Post-retirement Medical Benefit Plans To Determine Periodic Pension Costs) (details)
Pension And Other Post-retirement Benefit Plans (reconciliation Of Funded Status Of The Plans And The Amounts Included In The Company's Consolidated Balance Sheets) (details)
Pension And Other Post-retirement Benefit Plans (tables)
Pension And Other Post-retirement Benefit Plans (target Asset Allocations And Weighted Average Asset Allocations) (details)
Restructuring Activities
Restructuring Activities (narrative) (details)
Restructuring Activities (roll Forward Of Employee Termination Benefits And Other Restructuring Costs Liabilities) (details)
Restructuring Activities (summary Of Restructuring Costs) (details)
Restructuring Activities (tables)
Share Repurchases
Share Repurchases (narrative) (details)
Subsequent Events
Subsequent Events (details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policy)
Ticker: SIAL
CIK: 90185
Form Type: 10-K Annual Report
Accession Number: 0001193125-12-056253
Submitted to the SEC: Mon Feb 13 2012 4:26:52 PM EST
Accepted by the SEC: Mon Feb 13 2012
Period: Saturday, December 31, 2011
Industry: Wholesale Chemicals And Allied Products

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sial/0001193125-12-056253.htm